Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Probiotics Antimicrob Proteins ; 8(4): 183-190, 2016 12.
Article in English | MEDLINE | ID: mdl-27557837

ABSTRACT

Escherichia coli strains from swine origin, either susceptible or resistant to colistin, were grown under planktonic and biofilm cultures. After which, they were treated with antibacterial agents including nisin and enterocin DD14 bacteriocins, colistin and their combinations. Importantly, the combination of colistin, enterocin DD14 and nisin eradicated the planktonic and biofilm cultures of E. coli CIP54127 and the E. coli strains with colistin-resistance phenotype such as E. coli 184 (mcr-1 +) and E. coli 289 (mcr-1 -), suggesting therefore that bacteriocins from lactic acid bacteria could be used as agents with antibiotic augmentation capability.


Subject(s)
Bacteriocins/pharmacology , Colistin/pharmacology , Escherichia coli/drug effects , Animals , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Drug Synergism , Swine/microbiology
2.
Front Microbiol ; 7: 817, 2016.
Article in English | MEDLINE | ID: mdl-27303396

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) has become a worrisome superbug. This work aimed at studying the effects of two class IIb bacteriocins, enterocins DD28 and DD93 as anti-MRSA agents. Thus, these bacteriocins were purified, from the cultures supernatants of Enterococcus faecalis 28 and 93, using a simplified purification procedure consisting in a cation exchange chromatography and a reversed-phase high-performance liquid chromatography. The anti-Staphylococcal activity was shown in vitro by the assessment of the minimal inhibitory concentration (MIC), followed by a checkerboard and time-kill kinetics experiments. The data unveiled a clear synergistic effect of enterocins DD28 and DD93 in combination with erythromycin or kanamycin against the clinical MRSA-S1 strain. Besides, these combinations impeded as well the MRSA-S1 clinical strain to setup biofilms on stainless steel and glace devices.

3.
Res Microbiol ; 167(3): 215-21, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26723273

ABSTRACT

Five strains producing extended-spectrum ß-lactamases (ESBL) bacteria, identified as Escherichia coli, were isolated from children with urinary infections hospitalized at Roubaix hospital in the north of France. The DNA genotypes of these non-nosocomial isolates were determined by Random Amplified Polymorphic DNA (RAPD) method. Further, their DNA plasmids content revealed the presence of two distinct plasmids for S1, S2, S3 and one plasmid for S4 and S5. The antibacterial susceptibility of these ESBL bacteria was tested mainly against antibiotics of ß-lactams family. The ESBL producing bacteria were resistant to ticarcillin and cefotaxime but the combination of these antibiotics with colistin has dropped the MIC of ticarcillin below its breakpoint (isolates S2, S3 and S4), and has almost reached the breakpoint for cefotaxime (isolate S2). Thus, kill curves analyses carried out with only isolates S1 and S2, strengthened the bactericidal activity of the combinations of colistin-ticarcillin and colistin-cefotaxime against ESBL E. coli. Indeed, reduction of 3 log10 colony count were observed after 24 h of incubation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Colistin/pharmacology , Drug Synergism , Escherichia coli Infections/microbiology , Escherichia coli/drug effects , Urinary Tract Infections/microbiology , beta-Lactams/pharmacology , Child , DNA, Bacterial/genetics , Escherichia coli/classification , Escherichia coli/enzymology , Escherichia coli/isolation & purification , France , Hospitals , Humans , Microbial Sensitivity Tests , Microbial Viability/drug effects , Molecular Typing , Plasmids/analysis , Random Amplified Polymorphic DNA Technique , beta-Lactam Resistance , beta-Lactamases/metabolism
4.
Front Microbiol ; 6: 227, 2015.
Article in English | MEDLINE | ID: mdl-25883590

ABSTRACT

107 bacterial isolates with Gram positive staining and negative catalase activity, presumably assumed as lactic acid bacteria, were isolated from samples of meconium of 6 donors at Roubaix hospital, in the north of France. All these bacterial isolates were identified by MALDI-TOF mass spectrometry as Enterococcus faecalis. However, only six isolates among which E. faecalis 14, E. faecalis 28, E. faecalis 90, E. faecalis 97, and E. faecalis 101 (obtained from donor 3), and E. faecalis 93 (obtained from donor 5) were active against some Gram-negative bacteria and Gram-positive bacteria , through production of lactic acid, and bacteriocin like inhibitory substances. The identification of these isolates was confirmed by 16rDNA sequencing and their genetic relatedness was established by REP-PCR and pulsed field gel electrophoresis methods. Importantly, the aforementioned antagonistic isolates were sensitive to various classes of antibiotics tested, exhibited high scores of coaggregation and hydrophobicity, and were not hemolytic. Taken together, these properties render these strains as potential candidates for probiotic applications.

SELECTION OF CITATIONS
SEARCH DETAIL
...